Disentangling Nanotopography From Microroughness, Surface Chemistry, and Wettability in Osseointegration: A Critical Review and a Factorial Preclinical Protocol Built on Areal Surface Metrology
- Paper type
- Critical review with an embedded prospective preclinical study protocol
- Status
- Original Work · Working Paper
- Keywords:
- osseointegration · implant surface topography · nanotopography · surface wettability · areal roughness parameters · ISO 25178 · bone-to-implant contact · factorial design
Contents
- 1Introduction and Scientific Significance
- 2Critical Review of the Established Literature
- 3Identification of the Specific Research Gap
- 4Scientific Objective and Hypothesis
- 5Theoretical Foundation: Surface Metrology and Interface Physics
- 6Methodology
- 7Evidence Synthesis and Explicitly Labeled Theoretical Predictions
- 8Discussion: Mechanisms and Competing Explanations
- 9Implications for Implant Surgery and Restorative Dentistry
- 10Technical and Clinical Limitations
- 11Proposed Experimental and Clinical Validation
- 12Future Research Directions
- 13Evidence-Calibrated Conclusion
Abstract
Background: Moderately rough titanium surfaces integrate with bone more rapidly than turned surfaces, and most contemporary implants add a nanoscale texture or a hydrophilic chemistry to a microrough base. Because these modifications are produced by processes that change several surface properties at once, the independent contribution of nanotopography to bone formation has not been isolated.
Objective: To appraise what is established about surface microarchitecture and osseointegration, to identify why nanoscale effects remain uncertain, and to specify a study capable of refuting a defined hypothesis about them.
Methods: Critical narrative review of systematic reviews, Cochrane evidence, human histology, animal histomorphometry, and cell-level mechanistic work, with explicit separation of clinical, preclinical, in vitro, and theoretical evidence. A prospective 2 × 2 × 2 factorial preclinical protocol was then designed around areal (ISO 25178) surface characterization, X-ray photoelectron spectroscopy, and dynamic contact-angle measurement.
Findings: Preclinical evidence consistently favors moderately rough over smooth surfaces for early bone-to-implant contact, and hydrophilic microrough surfaces accelerate bone apposition during the first weeks without a demonstrated difference at later time points. Evidence for an independent nanoscale effect is confined largely to cell culture and to animal models in which chemistry, wettability, or microroughness co-varied with the nanofeature. Randomized clinical evidence does not show that any surface yields superior long-term implant survival, and suggests a lower early peri-implantitis risk for turned surfaces. We propose the hypothesis that, with areal height and hybrid parameters, chemistry, and contact angle held equivalent, nanofeatures alter 4-week bone-to-implant contact by fewer than 10 percentage points.
Conclusions: The clinical value of nanostructuring is unproven rather than disproven. Progress depends less on new surfaces than on factorial designs and standardized characterization that allow one property to be varied at a time. All predictions in this manuscript are theoretical and await experimental testing.
Keywords: osseointegration; implant surface topography; nanotopography; surface wettability; areal roughness parameters; ISO 25178; bone-to-implant contact; factorial design
1. Introduction and Scientific Significance
Osseointegration was defined operationally by Brånemark and colleagues as direct structural and functional contact between ordered living bone and the surface of a load-bearing implant, and the first decade of clinical experience with turned commercially pure titanium screws established that such an interface could persist under function [1]. Albrektsson and coworkers subsequently named six determinants of a durable interface: implant material, implant design, surface quality, the status of the host bone, surgical technique, and loading conditions [2]. Of these six, surface quality is the one that manufacturers can alter most freely, and it has been altered almost continuously for four decades.
The commercial result is a market in which nearly every implant carries a surface described as moderately rough, and in which many carry an additional claim: a nanostructured oxide, a discrete crystalline deposit, a fluoride-modified layer, or a chemically active hydrophilic state. Each claim rests on a plausible biological story. The clinical question is narrower and less comfortable. A surgeon choosing between two modern implants needs to know whether a nanoscale feature changes the probability or the speed of integration in the patient, and whether it does so at an acceptable cost to long-term peri-implant health. The scientific question underneath is whether the nanoscale feature does anything at all once the properties that accompany it are accounted for.
That question matters for three reasons. First, the healing interval that surface engineering aims to shorten is the same interval in which immediate and early loading protocols place implants at mechanical risk, so a real acceleration of bone apposition would have direct procedural consequences. Second, surface roughness that favors bone also favors biofilm retention once a surface is exposed to the oral environment, which means that an unproven benefit may be traded against a plausible harm. Third, regulatory clearance of surface modifications in the United States generally proceeds through substantial equivalence to predicate devices, a pathway that does not require demonstration of clinical superiority; the literature therefore accumulates surfaces faster than it accumulates comparative evidence about them.
This manuscript does not present a new surface. It examines why a question that has been studied for more than twenty years remains open, argues that the obstacle is a design and measurement problem and not a shortage of experiments, and specifies a protocol that could close it.
2. Critical Review of the Established Literature
Microscale roughness and bone response
The classic histomorphometric experiment of Buser and colleagues in miniature pigs compared titanium surfaces ranging from electropolished to sandblasted and acid-etched and to hydroxyapatite-coated, and found that the extent of bone-to-implant contact increased with increasing surface roughness [3]. Later work in the canine mandible showed that the advantage of a sandblasted and acid-etched surface over a titanium plasma-sprayed surface was maintained under both unloaded and loaded conditions [4], and paired comparisons of turned and microrough implants in the dog demonstrated earlier and more extensive bone formation on the rough surface during the first weeks of healing [5].
The systematic review by Wennerberg and Albrektsson remains the most rigorous synthesis of this preclinical literature [6]. Its most important finding is methodological. The large majority of the publications identified had to be excluded because the surfaces were inadequately characterized or the in vivo data were insufficient, and among the retained studies the authors could conclude only that smooth surfaces (Sa below 0.5 µm) and minimally rough surfaces (Sa 0.5 to 1.0 µm) showed weaker bone responses than rougher surfaces, with moderately rough surfaces (Sa 1.0 to 2.0 µm) tending to perform best in some studies. The same authors had earlier documented how variably roughness was measured and reported, and had proposed guidelines calling for three-dimensional measurement, defined filtering, and the reporting of at least one height, one spatial, and one hybrid parameter [7]. Two companion reviews catalogued the topographic and chemical properties of the principal commercial surfaces and the in vivo responses to them, again emphasizing that surfaces differing in name frequently differed in several properties at once [8, 9]. A subsequent overview reached the same position: the consensus in favor of moderately rough surfaces is real, but it rests on studies whose surface descriptions seldom permit a reader to say which property was responsible [10].
The biological sequence at the interface
Histological time-course studies in the dog, using a wound chamber formed by the implant thread geometry, described the sequence of de novo bone formation: a coagulum is replaced by granulation tissue within days, a provisional matrix is populated by mesenchymal cells, woven bone appears during the first week, and parallel-fibered and lamellar bone replace it over the following weeks [11]. Davies distinguished distance osteogenesis, in which bone advances from the osteotomy wall toward the implant, from contact osteogenesis, in which osteogenic cells migrate through the fibrin scaffold to the implant surface and deposit a cement-line matrix directly upon it [12, 13]. In this account the decisive function of surface topography is mechanical retention of the fibrin network against the contraction forces generated by migrating cells; a surface that retains fibrin permits osteoconduction to the surface, whereas a surface from which the clot detaches receives bone only by apposition from the wall. The framework explains why microscale texture should matter early and why its influence should diminish once the gap has been bridged. Reviews of early wound healing around implants and of the bone-implant interface as seen with modern ultrastructural methods support this general sequence while noting that the ultrastructure of the bonding zone remains debated [14–16].
Surface chemistry and wettability
Surface energy became a design variable when a sandblasted and acid-etched surface was produced under nitrogen and stored in isotonic saline to prevent hydrocarbon adsorption. In miniature pigs this chemically modified surface showed greater bone apposition than the conventional surface of identical microtopography at two and four weeks, with no difference at eight weeks [17]. Cell-culture work attributed the effect to enhanced osteoblast differentiation on high-energy microstructured substrates [18], a canine study reported earlier vascular and osseous organization [19], and a human histological study using retrievable experimental implants found more advanced osseointegration on the hydrophilic surface at intermediate healing times but similar values at six weeks [20]. The consistent pattern across species is acceleration without a demonstrated late difference.
Two reviews of implant wettability clarified the physics and exposed a confound [21, 22]. Apparent contact angle on a rough solid depends on both intrinsic surface energy and topography; on a wetting material, roughness amplifies hydrophilicity, and on a contaminated material it can produce air entrapment and apparent hydrophobicity [23]. Wettability is therefore neither a purely chemical nor a purely topographic property. Titanium surfaces also change with storage: adsorption of atmospheric hydrocarbons progressively lowers surface energy and has been associated with reduced protein adsorption, cell attachment, and bone-implant integration strength in a rat model, a phenomenon described as biological aging [24], and ultraviolet treatment that removes the hydrocarbon layer restored and enhanced bone integration in the same model [25]. Any experiment that compares surfaces of different storage history is thus also comparing surface carbon.
Nanoscale topography
The nanoscale literature is dominated by cell-culture evidence. Disordered arrays of nanopits induced osteogenic differentiation of human mesenchymal cells without chemical supplements, whereas highly ordered arrays did not [26]. Titanium dioxide nanotube diameter was reported to direct mesenchymal cell fate, but the two best-known studies reached different conclusions on the optimal dimension, one finding the smallest diameters most favorable to adhesion and differentiation with impaired viability on larger tubes [27], the other finding adhesion favored on small tubes and osteogenic differentiation on larger ones [28]. Superimposing nanoscale features on micro- and submicron-rough titanium enhanced osteoblast differentiation and local factor production relative to either scale alone [29], and microstructured substrates were shown to influence mesenchymal cells both directly and through factors secreted by osteoblasts on the surface [30]. Reviews of this field describe plausible mechanisms: altered adsorption and conformation of adhesive proteins, integrin clustering at a spacing dictated by the feature size, and cytoskeletal tension transmitted to the nucleus [31–33].
In vivo evidence is thinner and more confounded. Fluoride-modified blasted implants showed greater removal torque and bone contact than blasted controls in rabbits [34], but the modification alters chemistry as well as nanotopography. Oxidized surfaces have been proposed to bond to bone biochemically, a claim tied to oxide chemistry and thickness and not to texture alone [35]. The most informative experiments are those of Meirelles and colleagues, who deposited nanoscale hydroxyapatite or titania on electropolished cylinders deliberately devoid of microroughness and found enhanced early bone formation in rabbits [36, 37]. These studies come closest to isolating the nanoscale, yet the added material differed chemically from the substrate in one case, and removing microroughness answers a different question from the clinical one, which is whether a nanofeature adds anything to an already microrough surface. Characterization of commercial implants at the nanometer level showed, moreover, that marketed surfaces differ widely in whether they possess distinct nanostructures at all, and that some have none despite being moderately rough [38]. A systematic review of coatings and compositional modifications concluded that the preclinical data were too heterogeneous to rank them [39], and narrative syntheses of surface modifications repeat that conclusion [40, 41].
Clinical evidence
The Cochrane review of implant types found no evidence that any implant characteristic, including surface, produced superior long-term success, and reported limited evidence that implants with turned surfaces carried a lower risk of peri-implantitis at three years than implants with rough surfaces (risk ratio 0.80, 95% confidence interval 0.67 to 0.96) [42]. A large review of the reasons for implant failure identified turned surfaces as associated with higher early failure in some datasets, while emphasizing the multifactorial and confounded nature of the comparisons [43]. Taken together, the clinical record supports the view that microrough surfaces improved early outcomes in compromised bone and under shortened healing protocols; it offers no trial-level evidence that nanoscale or hydrophilic modifications changed survival, and it flags a possible long-term cost of roughness once the surface is exposed.
The immune interpretation
A further body of work treats osseointegration as an immunologically governed foreign-body equilibrium in which bone is deposited to wall off the implant and marginal bone loss represents a shift in that equilibrium [44, 45]. Macrophage phenotype responds to surface properties: rough hydrophilic titanium promoted an anti-inflammatory activation profile in vitro relative to smooth or hydrophobic titanium [46]. If surface properties act chiefly through early immune polarization, then histomorphometric endpoints at four to eight weeks may register a downstream effect of a much earlier event, and nanoscale features might matter through protein adsorption and macrophage signaling even where they do not change osteoblast behavior directly. The interpretation is unproven in humans, but it widens the set of mechanisms a decisive experiment must be able to distinguish.
3. Identification of the Specific Research Gap
Four statements summarize the state of knowledge. Microroughness in the range of roughly 1 to 2 µm in Sa is associated with faster and more extensive early bone contact than smooth surfaces in animals. High surface energy accelerates early apposition on a microrough base in animals and in human histology, without a demonstrated difference after six to eight weeks. Nanoscale features alter cell behavior in culture in ways that depend on feature size, order, and chemistry. No randomized clinical evidence shows a survival or success advantage for any nanostructured or hydrophilic surface.
What remains uncertain is whether nanotopography has an effect on bone formation in vivo that is independent of the three properties with which it is almost always confounded. The confounding is structural. Anodization that grows nanotubes also thickens and may crystallize the oxide and incorporate electrolyte ions. Acid etching that produces nanoscale pits changes the hybrid roughness parameters and surface hydride content. Discrete crystalline deposition adds calcium phosphate chemistry. Wet storage that preserves hydrophilicity also promotes the spontaneous growth of nanostructures on the oxide during aging in aqueous media, so that surfaces marketed as hydrophilic differ from their dry counterparts in nanotopography as well as in energy [22]. An experiment comparing commercial surface A with commercial surface B therefore compares bundles of properties.
The methods are inadequate in three specific respects. Roughness is commonly reported as a single profile parameter (Ra) obtained with a contact stylus whose tip radius exceeds the features of interest, although areal optical methods and standardized areal parameters are available [47]. Chemistry is often inferred from the manufacturing process instead of being measured at the surface. And designs are almost always one-factor comparisons, which cannot estimate interactions; yet the cell-level evidence that nanofeatures act synergistically with microroughness [29] is precisely a claim about an interaction.
4. Scientific Objective and Hypothesis
The objective is to determine whether nanoscale topography exerts an effect on early peri-implant bone formation that is separable from microroughness, surface chemistry, and wettability.
We state the hypothesis in a form that can fail. Hypothesis H1: when areal height roughness (Sa), developed interfacial area ratio (Sdr), surface elemental composition, and dynamic water contact angle are held within prespecified equivalence bounds, the presence of nanofeatures with characteristic lateral dimensions of 10 to 100 nm changes bone-to-implant contact at 4 weeks by fewer than 10 percentage points in an established large-animal model.
H1 is an equivalence claim, chosen deliberately. The prevailing assumption in product literature is that nanofeatures help; the conservative scientific position is that an independent effect of clinically relevant size has not been shown. H1 would be falsified by a main effect of nanotopography of 10 percentage points or more with a 95% confidence interval excluding zero. It would be supported, in the equivalence sense, if the 90% confidence interval for the main effect lay entirely within plus or minus 10 points. An estimate whose interval spans the margin would leave the question open and would be reported as inconclusive. A secondary hypothesis, H1b, concerns the interaction: that any nanoscale effect is larger on a microrough than on a smooth base. H1b is falsified if the interaction contrast is smaller than 5 percentage points with an interval excluding the 10-point margin.
The 10-point margin is a judgment, and it is stated so that it can be challenged. It corresponds approximately to the magnitude of differences in bone contact that have been reported between hydrophilic and conventional microrough surfaces at early time points in animal studies, differences that did not persist and have not been shown to alter clinical outcome. A nanoscale effect smaller than this would be unlikely to matter to a patient.
5. Theoretical Foundation: Surface Metrology and Interface Physics
Areal parameters
Let z(x, y) denote surface height relative to the mean plane over an evaluation area A after form removal and filtering. The arithmetic mean height is
S_a = 1/A ∬ |z(x,y)| dx dy (1)
expressed in micrometers. Sa describes amplitude only; two surfaces of identical Sa can differ entirely in the lateral scale and slope of their features. The developed interfacial area ratio captures that difference:
S_(dr) = (A_(true) - A_(proj))/(A_(proj)) × 100 (2)
where Atrue is the area of the measured texture, Aproj is the projected (nominal) area, and Sdr is expressed as a percentage. Because Sdr depends on local slopes, it is sensitive to fine-scale texture and therefore to the measurement bandwidth. This is the crux of the metrological problem: nanofeatures contribute little to Sa but can contribute substantially to Sdr if the instrument resolves them, and nothing if it does not. A statement that two surfaces have "the same roughness" is meaningless without the lateral resolution, the sampling interval, and the filter cutoffs (the S-filter that removes short-wavelength noise and the L-filter that removes long-wavelength form) [7, 47].
We therefore define two bandwidths. The microscale band, measured by optical interferometry or confocal microscopy with nesting indices on the order of 1 µm (S-filter) and 50 µm (L-filter), yields Sa,micro and Sdr,micro. The nanoscale band, measured by atomic force microscopy over areas of 1 to 25 µm2 with nesting indices on the order of 10 nm and 1 µm, yields Sa,nano, Sdr,nano, and a feature density. "Equivalent microroughness" in this protocol means equivalence of the microscale-band parameters; the experimental factor "nanotopography" is defined by the nanoscale-band parameters. The definitions are arbitrary at the boundary, as any scale separation is, but they are explicit and reproducible.
Wettability on rough solids
For a chemically homogeneous rough surface wetted in the Wenzel state, the apparent contact angle θ* is related to the intrinsic (Young) angle θY of the flat material by
cos θ^* = r cos θ_Y (3)
where r is the dimensionless ratio of true to projected area, so that r = 1 + Sdr/100 when the full bandwidth is resolved [23]. The relation has a direct consequence for experimental design: adding nanofeatures raises r and therefore changes the apparent contact angle even when chemistry is constant. To hold wettability equivalent while varying nanotopography, the intrinsic surface energy must be adjusted in the opposite direction, or wettability must be treated as a separate factor and crossed with nanotopography. The protocol below does the latter, because adjusting intrinsic energy would reintroduce a chemical difference.
A minimal model of early bone contact
To make the hypothesis quantitative we describe bone-to-implant contact at time t, B(t), as the sum of contributions from contact and distance osteogenesis, each approaching a plateau:
B(t) = B_c(1 - e^(-k_c t)) + B_d(1 - e^(-k_d t)) (4)
where Bc and Bd are the asymptotic contributions (percent of surface length) and kc and kd are rate constants (per week). In Davies's framework, surface properties act primarily on Bc and kc through clot retention and cell recruitment, whereas kd is governed by host bone and defect geometry [13]. The model is descriptive and its parameters are not known for any surface; its use here is to show why a single time point is insufficient. A surface that raises kc without changing the plateau produces a difference at two to four weeks that vanishes by eight, which is the pattern reported for hydrophilic surfaces [17, 20]. A surface that raises Bc produces a persistent difference. The protocol therefore samples three time points so that rate and plateau effects can be distinguished.
6. Methodology
Review methods
The review component is a critical narrative synthesis, not a systematic review, and should be reported as such. Sources were limited to peer-reviewed publications indexed in PubMed and to one international standard. Systematic reviews and Cochrane evidence were given priority for clinical claims; for mechanistic claims, the original experimental reports were used. Evidence was classified as clinical, preclinical in vivo, in vitro, or theoretical, and that classification is carried through the text. A full systematic review restricted to in vivo studies that report areal roughness, surface chemistry, and contact angle for both test and control surfaces would be a worthwhile separate project and should follow PRISMA 2020; a scoping search suggests that the number of eligible studies would be small, which is itself the finding of interest.
Experimental design of the proposed study
The proposed experiment is a 2 × 2 × 2 full factorial with factors microroughness (smooth, Sa,micro below 0.5 µm; moderately rough, Sa,micro 1.0 to 2.0 µm), nanotopography (absent; present, with characteristic lateral feature size 10 to 100 nm), and wettability (hydrophobic, advancing water contact angle above 90 degrees; hydrophilic, below 20 degrees). The eight surface conditions are produced on implants of identical macrogeometry machined from a single lot of grade 4 commercially pure titanium.
The manufacturing strategy is chosen to decouple the factors. Microroughness is produced by a single blasting and etching sequence. Nanotopography is added by a process that does not introduce a new chemical species; candidate routes include controlled oxidative treatment that grows nanoscale oxide features, with the "absent" level receiving a matched thermal and chemical history that does not nucleate nanostructures. Wettability is set last, by ultraviolet or plasma cleaning immediately before packaging in an inert environment for the hydrophilic level, and by controlled hydrocarbon re-adsorption for the hydrophobic level, following the aging phenomenon described for titanium [24, 25]. Whether a given process actually achieves decoupling is an empirical matter, which is why surface release criteria (Section 6.3) are applied to every lot before any implant is placed. A design that cannot meet its release criteria has failed at the bench and should not proceed to animals.
Surface characterization and release criteria
Each surface condition is characterized on at least three implants at three sites per implant (thread crest, flank, and root), following established guidance [7]. The minimum reporting set is given in Table 1. Equivalence bounds are prespecified: between levels of a factor that is meant to be constant, Sa,micro must agree within 0.2 µm, Sdr,micro within 15 percent of the mean, atomic concentrations of titanium, oxygen, and carbon by X-ray photoelectron spectroscopy within 5 atomic percent, with no element present in one condition and absent from its comparator above 1 atomic percent, and advancing contact angle within 10 degrees. Oxide thickness and crystalline phase are measured and reported; if they differ between nanotopography levels, the difference is declared as an unresolved confound.
| Property | Method and conditions | Parameters to report |
|---|---|---|
| Microscale topography | Optical interferometry or confocal microscopy; stated objective, sampling interval, S-filter and L-filter nesting indices | Sa, Sq, Ssk, Sdr, Spd, Str with mean and SD across 9 or more sites |
| Nanoscale topography | Atomic force microscopy or high-resolution scanning electron microscopy with image analysis; stated scan size and tip radius | Sa,nano, Sdr,nano, feature lateral size distribution, feature density, order metric |
| Elemental composition | X-ray photoelectron spectroscopy survey and high-resolution scans | Atomic percent Ti, O, C, N and any trace element above 0.5 at%; carbon-to-titanium ratio |
| Oxide layer | Depth profiling or transmission electron microscopy; Raman or grazing-incidence diffraction | Thickness, crystalline phase |
| Wettability | Dynamic (Wilhelmy) or sessile-drop contact angle within a stated time of unpackaging | Advancing and receding angle, time from package opening, storage medium and duration |
| Cleanliness and sterility history | Stated sterilization method and packaging | Method, dose, packaging atmosphere, shelf time |
Animal model, allocation, and outcomes
The model is the mandible or tibia of a skeletally mature large animal in which multiple implants can be placed per animal; the miniature pig and the dog both have a literature of comparable experiments [3, 5]. Each animal receives all eight conditions in randomized positions, which makes animal a blocking factor and removes between-animal variance from the treatment contrasts. Implants are placed with a standardized drilling protocol to a defined insertion torque window and allowed to heal submerged and unloaded. Animals are randomized to sacrifice at 2, 4, or 8 weeks. Surgeons are blind to surface condition, which is feasible because the surfaces are not visually distinguishable within a microroughness level; histomorphometric assessors are blind to all factors.
The primary outcome is bone-to-implant contact at 4 weeks, measured on undecalcified ground sections as the percentage of implant perimeter in direct contact with mineralized bone within a defined region of interest. Secondary outcomes are bone-to-implant contact at 2 and 8 weeks, bone area within threads, removal torque on a separate implant set, and, on retrieved peri-implant tissue at 3 and 7 days in a satellite cohort, markers of macrophage polarization, so that the immune interpretation [45, 46] can be examined directly. Reporting follows ARRIVE 2.0 [48], and the protocol requires approval by an institutional animal care and use committee before initiation; no such approval has been sought for this theoretical manuscript.
Statistical analysis and sample size
The primary analysis is a linear mixed model for 4-week bone-to-implant contact with fixed effects for the three factors and their interactions and a random intercept for animal. The main effect of nanotopography is estimated with its 95% and 90% confidence intervals and compared with the 10-point margin as specified in Section 4. In a full factorial with n animals per time point, each main effect is estimated from 4n observations per level. For a two-sided test of a difference Δ with within-animal residual standard deviation σ, type I error α, and power 1 − β, the required number of observations per level is approximately
N = (2 (z_(1-α/2) + z_(1-β))^2 σ^2)/(Δ^2) (5)
where z denotes the standard normal quantile. With Δ = 10 percentage points, α = 0.05, power 0.80, and an assumed σ of 12 points, N is approximately 23 observations per level, which corresponds to 6 animals per time point. The standard deviation is an assumption drawn from the general range of variability in large-animal histomorphometry and must be replaced with a pilot estimate; Figure 1 shows how strongly the requirement depends on it. Demonstrating equivalence within the same margin requires a larger sample than detecting a difference of that size, and the protocol accordingly specifies 10 animals per time point, to be confirmed after a pilot.
7. Evidence Synthesis and Explicitly Labeled Theoretical Predictions
What the existing evidence supports
Table 2 grades the principal claims by the type of evidence behind them. The grading is qualitative and reflects the authors' reading of the cited sources; it is not the output of a formal GRADE process.
| Claim | Highest level of supporting evidence | Principal limitation |
|---|---|---|
| Moderately rough surfaces achieve greater early bone contact than smooth surfaces [3, 6] | Preclinical in vivo; systematic review of animal studies | Heterogeneous and often inadequate surface characterization |
| Hydrophilic microrough surfaces accelerate early bone apposition [17, 20] | Preclinical in vivo; human histology | No difference shown at later time points; wet storage may alter nanotopography |
| Nanofeatures direct mesenchymal cell differentiation [26–28] | In vitro | Conflicting optimal dimensions; chemistry and crystallinity vary with feature size |
| Nanofeatures enhance bone formation in vivo independent of other properties [36, 37] | Preclinical in vivo, few studies | Tested on substrates without microroughness; added chemistry in some conditions |
| Any modern surface improves long-term implant survival over another [42] | Randomized trials (no difference shown) | Trials underpowered for rare failures; short follow-up |
| Rough surfaces increase peri-implantitis risk relative to turned surfaces [42] | Randomized trials, limited | Few trials; surfaces now marketed differ from those tested |
Theoretical predictions
The following are predictions derived from the framework in Section 5. They are not results.
Prediction 1. Under H1, the main effect of nanotopography on 4-week bone-to-implant contact will be smaller than the main effects of microroughness and of wettability. The basis is Davies's mechanism: clot retention operates at the scale of fibrin fibers, which are of the order of hundreds of nanometers in diameter and are anchored by features of micrometer and submicrometer size [13].
Prediction 2. If nanofeatures act mainly through protein adsorption and early immune signaling, their effect will be detectable in the satellite cohort as a shift in macrophage markers at 3 to 7 days even if the histomorphometric difference at 4 weeks falls inside the equivalence margin. That outcome would support H1 at the tissue level while identifying a biological effect of uncertain consequence.
Prediction 3. Because nanofeatures increase the true-to-projected area ratio, the hydrophilic-with-nanofeature condition will show the lowest apparent contact angle of all eight conditions (Equation 3), and any apparent "nano" benefit observed in one-factor studies of hydrophilic surfaces may be reproduced here as a wettability main effect.
Prediction 4. In the kinetic model (Equation 4), an effect confined to the rate constant predicts a nanotopography effect at 2 weeks that is larger than at 4 weeks and absent at 8 weeks. An effect on the plateau predicts the opposite ordering.
8. Discussion: Mechanisms and Competing Explanations
Three explanations compete for the observation that nanostructured commercial surfaces often perform well in animal comparisons. The first is the direct mechanobiological account: nanofeatures constrain integrin clustering and focal adhesion maturation, raise cytoskeletal tension, and bias mesenchymal cells toward the osteoblast lineage [26, 31]. Its strength is the reproducibility of the cell-culture phenomenon; its weakness is the inconsistency of the reported optimal dimensions [27, 28] and the distance between a monoculture on a flat coupon and a blood-filled osteotomy, where the first material to meet the surface is plasma protein and the first cells are platelets and leukocytes.
The second explanation is that nanostructuring is a marker for surface cleanliness and energy. Processes that create nanofeatures often leave a fresh, hydroxylated, low-carbon oxide, and the performance attributed to texture may belong to chemistry. The biological-aging experiments, in which nominally identical surfaces lost osteoconductivity with storage and regained it with ultraviolet treatment, show that surface carbon alone can produce effects of the size at issue [24, 25]. Under this explanation a nanostructured surface stored dry for a year and a non-nanostructured surface freshly cleaned would reverse their ranking.
The third explanation is metrological. If nanofeatures increase Sdr and thereby the area available for protein adsorption and the mechanical interlock with the cement-line matrix, then "nanotopography" and "hybrid roughness" are partly the same variable measured in different bandwidths. The proposed design addresses this by defining the factor in the nanoscale band and constraining the microscale band, but it cannot abolish the continuity between scales. If H1 is falsified, a follow-up study would be needed to determine whether the effect tracks feature size and order, as the mechanobiological account requires, or simply tracks total developed area.
The immune interpretation cuts across all three. If the early macrophage response sets the trajectory of bone formation [45, 46], then chemistry, energy, and nanotopography may all converge on protein-layer composition as a common mediator, and the factorial experiment will show interactions and not clean main effects. That would be an informative result. It would imply that surface design should be evaluated by the adsorbed protein layer and early cellular response it produces, and that naming a surface by its fabrication process conveys little.
The clinical counterweight must be kept in view. Roughness that accelerates integration is the same roughness that complicates decontamination once threads are exposed, and the only randomized evidence that distinguishes surfaces by a patient-relevant outcome points toward lower early peri-implantitis risk with turned surfaces [42]. A nanoscale modification that leaves microroughness unchanged would not obviously worsen that trade-off, which is an argument for studying nanofeatures on minimally rough substrates; the proposed factorial includes that cell.
9. Implications for Implant Surgery and Restorative Dentistry
For the practicing surgeon the present evidence supports a restrained position. Selection of a moderately rough surface is justified by consistent preclinical evidence and long clinical experience. Selection of one moderately rough implant over another because of a nanoscale or hydrophilic feature is not supported by clinical outcome data; where such a surface is chosen for a shortened loading protocol, the choice rests on animal and human histological evidence of faster early apposition, which is biologically reasonable but has not been shown to reduce failure. Hydrophilic implants should be handled as the manufacturer directs, since exposure to air before placement changes the property being paid for.
For the restorative clinician the implication concerns timing, not surface. Decisions about early loading should be driven by measured primary stability, bone quality, and occlusal control, with surface chemistry treated as a possible modifier of small and uncertain size.
For journals and reviewers, the implication is a reporting standard. A comparative surface study that does not report the items in Table 1 for both test and control surfaces cannot attribute its findings to a named property and should say so in its limitations.
10. Technical and Clinical Limitations
The review is narrative, and although it draws on systematic reviews it does not claim completeness; relevant studies, particularly of proprietary surfaces, may have been missed. The preclinical literature is subject to publication bias in favor of positive surface effects, which would inflate the apparent benefit of every modification discussed.
The proposed experiment has limits of its own. Perfect decoupling of nanotopography from oxide thickness and crystallinity may not be achievable, and the protocol can only measure and declare residual differences. The scale separation between micro and nano bands is a convention. Bone-to-implant contact on ground sections samples a small fraction of the interface, is sensitive to section plane, and is a surrogate for mechanical and clinical performance. Healthy animal bone with rapid turnover overstates healing capacity relative to the irradiated, osteoporotic, or diabetic human sites in which a surface advantage would matter most. The design tests one family of nanofeatures; a null result would not exclude an effect of a different geometry. Finally, the equivalence margin is a judgment that others may reasonably set differently, and the conclusion drawn from the same data would change with it.
11. Proposed Experimental and Clinical Validation
Validation proceeds in stages, each with a stopping rule. Stage 1 is bench validation of the eight surfaces against the release criteria in Section 6.3 by a laboratory independent of the manufacturer, including a storage study in which contact angle and surface carbon are tracked over the intended shelf interval. Failure to meet equivalence bounds stops the program or forces redesign. Stage 2 is an in vitro screen with human mesenchymal cells and macrophages, used to confirm that the surfaces elicit the differences reported in the literature and not to predict in vivo outcome. Stage 3 is the factorial animal experiment described above, preceded by a pilot to estimate the residual standard deviation. Stage 4, conditional on falsification of H1, is a dose-response animal study varying feature size at fixed developed area.
Clinical validation would be warranted only if Stage 3 showed an effect exceeding the margin. The appropriate design would be a randomized, split-mouth or parallel-group trial reported under CONSORT, comparing implants identical in macrodesign and microroughness and differing in the nanoscale factor, with stability kinetics measured by resonance frequency analysis during the first 12 weeks as a mechanistic outcome and with implant failure and marginal bone level as clinical outcomes. Because failure is rare, such a trial could not be powered on survival alone and would have to be honest about that.
12. Future Research Directions
Three directions follow from the argument. The first is methodological infrastructure: an open reference set of titanium coupons with certified areal parameters at both bandwidths, against which laboratories could calibrate, would do more for comparability than another surface. The second is mediator-focused biology: proteomic characterization of the layer adsorbed from human plasma on each of the eight factorial surfaces would test whether a common mediator underlies chemistry, energy, and nanotopography effects. The third is compromised-host models. If nanoscale effects are small in healthy bone, the relevant question becomes whether they are larger where healing is impaired, and the factorial approach transfers directly to diabetic or irradiated animal models. A fourth direction, outside the scope of this paper, concerns the behavior of nanostructured surfaces under biofilm challenge and decontamination, where the long-term cost of surface complexity would be measured.
13. Evidence-Calibrated Conclusion
Moderately rough implant surfaces integrate faster than smooth ones in animals, and high-energy microrough surfaces accelerate early apposition in animals and in human histology. Those conclusions are supported by preclinical evidence of moderate consistency and by limited human histological data. That nanoscale topography contributes independently to bone formation in vivo is a hypothesis supported by cell-culture evidence and by a small number of confounded animal studies; it has not been tested in a design that holds microroughness, chemistry, and wettability constant, and no clinical trial shows that it changes implant survival. We have proposed that the independent effect is smaller than 10 percentage points of bone contact at 4 weeks, specified the factorial experiment and the surface-release criteria that could refute that proposal, and identified the measurements without which no surface comparison can be interpreted. Until such an experiment is done, claims for nanostructured surfaces should be read as claims about bundles of properties.
Cite this paper
Jain S, Gupta A. Disentangling Nanotopography From Microroughness, Surface Chemistry, and Wettability in Osseointegration: A Critical Review and a Factorial Preclinical Protocol Built on Areal Surface Metrology. Working paper. Center for Implant Dentistry; 2026. Available from: https://bayareaimplantdentistry.com/clinician-research-and-publications/isolating-the-nanoscale-contribution-to-osseointegration
References
- Brånemark PI, Hansson BO, Adell R, Breine U, Lindström J, Hallén O, et al. Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl. 1977;16:1-132. PMID: 356184 (opens in a new tab).
- Albrektsson T, Brånemark PI, Hansson HA, Lindström J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand. 1981;52(2):155-70. doi:10.3109/17453678108991776 (opens in a new tab) PMID: 7246093 (opens in a new tab).
- Buser D, Schenk RK, Steinemann S, Fiorellini JP, Fox CH, Stich H. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res. 1991;25(7):889-902. doi:10.1002/jbm.820250708 (opens in a new tab) PMID: 1918105 (opens in a new tab).
- Cochran DL, Schenk RK, Lussi A, Higginbottom FL, Buser D. Bone response to unloaded and loaded titanium implants with a sandblasted and acid-etched surface: a histometric study in the canine mandible. J Biomed Mater Res. 1998;40(1):1-11. doi:10.1002/(sici)1097-4636(199804)40:1<1::aid-jbm1>3.0.co;2-q (opens in a new tab) PMID: 9511093 (opens in a new tab).
- Abrahamsson I, Berglundh T, Linder E, Lang NP, Lindhe J. Early bone formation adjacent to rough and turned endosseous implant surfaces. An experimental study in the dog. Clin Oral Implants Res. 2004;15(4):381-92. doi:10.1111/j.1600-0501.2004.01082.x (opens in a new tab) PMID: 15248872 (opens in a new tab).
- Wennerberg A, Albrektsson T. Effects of titanium surface topography on bone integration: a systematic review. Clin Oral Implants Res. 2009;20 Suppl 4:172-84. doi:10.1111/j.1600-0501.2009.01775.x (opens in a new tab) PMID: 19663964 (opens in a new tab).
- Wennerberg A, Albrektsson T. Suggested guidelines for the topographic evaluation of implant surfaces. Int J Oral Maxillofac Implants. 2000;15(3):331-44. PMID: 10874798 (opens in a new tab).
- Albrektsson T, Wennerberg A. Oral implant surfaces: Part 1--review focusing on topographic and chemical properties of different surfaces and in vivo responses to them. Int J Prosthodont. 2004;17(5):536-43. PMID: 15543910 (opens in a new tab).
- Albrektsson T, Wennerberg A. Oral implant surfaces: Part 2--review focusing on clinical knowledge of different surfaces. Int J Prosthodont. 2004;17(5):544-64. PMID: 15543911 (opens in a new tab).
- Wennerberg A, Albrektsson T. On implant surfaces: a review of current knowledge and opinions. Int J Oral Maxillofac Implants. 2010;25(1):63-74. PMID: 20209188 (opens in a new tab).
- Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res. 2003;14(3):251-62. doi:10.1034/j.1600-0501.2003.00972.x (opens in a new tab) PMID: 12755774 (opens in a new tab).
- Davies JE. Mechanisms of endosseous integration. Int J Prosthodont. 1998;11(5):391-401. PMID: 9922731 (opens in a new tab).
- Davies JE. Understanding peri-implant endosseous healing. J Dent Educ. 2003;67(8):932-49. PMID: 12959168 (opens in a new tab).
- Raghavendra S, Wood MC, Taylor TD. Early wound healing around endosseous implants: a review of the literature. Int J Oral Maxillofac Implants. 2005;20(3):425-31. PMID: 15973954 (opens in a new tab).
- Shah FA, Thomsen P, Palmquist A. Osseointegration and current interpretations of the bone-implant interface. Acta Biomater. 2019;84:1-15. doi:10.1016/j.actbio.2018.11.018 (opens in a new tab) PMID: 30445157 (opens in a new tab).
- Bosshardt DD, Chappuis V, Buser D. Osseointegration of titanium, titanium alloy and zirconia dental implants: current knowledge and open questions. Periodontol 2000. 2017;73(1):22-40. doi:10.1111/prd.12179 (opens in a new tab) PMID: 28000277 (opens in a new tab).
- Buser D, Martin W, Belser UC. Optimizing esthetics for implant restorations in the anterior maxilla: anatomic and surgical considerations. Int J Oral Maxillofac Implants. 2004;19 Suppl:43-61. PMID: 15635945 (opens in a new tab).
- Zhao G, Schwartz Z, Wieland M, Rupp F, Geis-Gerstorfer J, Cochran DL, et al. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res A. 2005;74(1):49-58. doi:10.1002/jbm.a.30320 (opens in a new tab) PMID: 15924300 (opens in a new tab).
- Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA titanium implants: preliminary results of a pilot study in dogs. Clin Oral Implants Res. 2007;18(4):481-8. doi:10.1111/j.1600-0501.2007.01341.x (opens in a new tab) PMID: 17484737 (opens in a new tab).
- Lang NP, Salvi GE, Huynh-Ba G, Ivanovski S, Donos N, Bosshardt DD. Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans. Clin Oral Implants Res. 2011;22(4):349-56. doi:10.1111/j.1600-0501.2011.02172.x (opens in a new tab) PMID: 21561476 (opens in a new tab).
- Rupp F, Gittens RA, Scheideler L, Marmur A, Boyan BD, Schwartz Z, et al. A review on the wettability of dental implant surfaces I: theoretical and experimental aspects. Acta Biomater. 2014;10(7):2894-906. doi:10.1016/j.actbio.2014.02.040 (opens in a new tab) PMID: 24590162 (opens in a new tab).
- Gittens RA, Scheideler L, Rupp F, Hyzy SL, Geis-Gerstorfer J, Schwartz Z, et al. A review on the wettability of dental implant surfaces II: Biological and clinical aspects. Acta Biomater. 2014;10(7):2907-18. doi:10.1016/j.actbio.2014.03.032 (opens in a new tab) PMID: 24709541 (opens in a new tab).
- Wenzel RN. Resistance of solid surfaces to wetting by water. Ind Eng Chem. 1936;28(8):988-94. †
- Att W, Hori N, Takeuchi M, Ouyang J, Yang Y, Anpo M, et al. Time-dependent degradation of titanium osteoconductivity: an implication of biological aging of implant materials. Biomaterials. 2009;30(29):5352-63. doi:10.1016/j.biomaterials.2009.06.040 (opens in a new tab) PMID: 19595450 (opens in a new tab).
- Aita H, Hori N, Takeuchi M, Suzuki T, Yamada M, Anpo M, et al. The effect of ultraviolet functionalization of titanium on integration with bone. Biomaterials. 2009;30(6):1015-25. doi:10.1016/j.biomaterials.2008.11.004 (opens in a new tab) PMID: 19042016 (opens in a new tab).
- Dalby MJ, Gadegaard N, Tare R, Andar A, Riehle MO, Herzyk P, et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater. 2007;6(12):997-1003. doi:10.1038/nmat2013 (opens in a new tab) PMID: 17891143 (opens in a new tab).
- Park J, Bauer S, von der Mark K, Schmuki P. Nanosize and vitality: TiO2 nanotube diameter directs cell fate. Nano Lett. 2007;7(6):1686-91. doi:10.1021/nl070678d (opens in a new tab) PMID: 17503870 (opens in a new tab).
- Oh S, Brammer KS, Li YS, Teng D, Engler AJ, Chien S, et al. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A. 2009;106(7):2130-5. doi:10.1073/pnas.0813200106 (opens in a new tab) PMID: 19179282 (opens in a new tab).
- Gittens RA, McLachlan T, Olivares-Navarrete R, Cai Y, Berner S, Tannenbaum R, et al. The effects of combined micron-/submicron-scale surface roughness and nanoscale features on cell proliferation and differentiation. Biomaterials. 2011;32(13):3395-403. doi:10.1016/j.biomaterials.2011.01.029 (opens in a new tab) PMID: 21310480 (opens in a new tab).
- Olivares-Navarrete R, Hyzy SL, Hutton DL, Erdman CP, Wieland M, Boyan BD, et al. Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage. Biomaterials. 2010;31(10):2728-35. doi:10.1016/j.biomaterials.2009.12.029 (opens in a new tab) PMID: 20053436 (opens in a new tab).
- Mendonça G, Mendonça DB, Aragão FJ, Cooper LF. Advancing dental implant surface technology--from micron- to nanotopography. Biomaterials. 2008;29(28):3822-35. doi:10.1016/j.biomaterials.2008.05.012 (opens in a new tab) PMID: 18617258 (opens in a new tab).
- Souza JCM, Sordi MB, Kanazawa M, Ravindran S, Henriques B, Silva FS, et al. Nano-scale modification of titanium implant surfaces to enhance osseointegration. Acta Biomater. 2019;94:112-131. doi:10.1016/j.actbio.2019.05.045 (opens in a new tab) PMID: 31128320 (opens in a new tab).
- Boyan BD, Lotz EM, Schwartz Z. Roughness and Hydrophilicity as Osteogenic Biomimetic Surface Properties. Tissue Eng Part A. 2017;23(23-24):1479-1489. doi:10.1089/ten.TEA.2017.0048 (opens in a new tab) PMID: 28793839 (opens in a new tab).
- Ellingsen JE, Johansson CB, Wennerberg A, Holmén A. Improved retention and bone-tolmplant contact with fluoride-modified titanium implants. Int J Oral Maxillofac Implants. 2004;19(5):659-66. PMID: 15508981 (opens in a new tab).
- Sul YT. The significance of the surface properties of oxidized titanium to the bone response: special emphasis on potential biochemical bonding of oxidized titanium implant. Biomaterials. 2003;24(22):3893-907. doi:10.1016/s0142-9612(03)00261-8 (opens in a new tab) PMID: 12834584 (opens in a new tab).
- Meirelles L, Arvidsson A, Andersson M, Kjellin P, Albrektsson T, Wennerberg A. Nano hydroxyapatite structures influence early bone formation. J Biomed Mater Res A. 2008;87(2):299-307. doi:10.1002/jbm.a.31744 (opens in a new tab) PMID: 18181110 (opens in a new tab).
- Meirelles L, Currie F, Jacobsson M, Albrektsson T, Wennerberg A. The effect of chemical and nanotopographical modifications on the early stages of osseointegration. Int J Oral Maxillofac Implants. 2008;23(4):641-7. PMID: 18807559 (opens in a new tab).
- Svanborg LM, Andersson M, Wennerberg A. Surface characterization of commercial oral implants on the nanometer level. J Biomed Mater Res B Appl Biomater. 2010;92(2):462-9. doi:10.1002/jbm.b.31538 (opens in a new tab) PMID: 19957360 (opens in a new tab).
- Junker R, Dimakis A, Thoneick M, Jansen JA. Effects of implant surface coatings and composition on bone integration: a systematic review. Clin Oral Implants Res. 2009;20 Suppl 4:185-206. doi:10.1111/j.1600-0501.2009.01777.x (opens in a new tab) PMID: 19663965 (opens in a new tab).
- Smeets R, Stadlinger B, Schwarz F, Beck-Broichsitter B, Jung O, Precht C, et al. Impact of Dental Implant Surface Modifications on Osseointegration. Biomed Res Int. 2016;2016:6285620. doi:10.1155/2016/6285620 (opens in a new tab) PMID: 27478833 (opens in a new tab).
- Coelho PG, Bonfante EA, Silva NR, Rekow ED, Thompson VP. Laboratory simulation of Y-TZP all-ceramic crown clinical failures. J Dent Res. 2009;88(4):382-6. doi:10.1177/0022034509333968 (opens in a new tab) PMID: 19407162 (opens in a new tab).
- Esposito M, Ardebili Y, Worthington HV. Interventions for replacing missing teeth: different types of dental implants. Cochrane Database Syst Rev. 2014(7):CD003815. doi:10.1002/14651858.CD003815.pub4 (opens in a new tab) PMID: 25048469 (opens in a new tab).
- Chrcanovic BR, Albrektsson T, Wennerberg A. Reasons for failures of oral implants. J Oral Rehabil. 2014;41(6):443-76. doi:10.1111/joor.12157 (opens in a new tab) PMID: 24612346 (opens in a new tab).
- Albrektsson T, Dahlin C, Jemt T, Sennerby L, Turri A, Wennerberg A. Is marginal bone loss around oral implants the result of a provoked foreign body reaction? Clin Implant Dent Relat Res. 2014;16(2):155-65. doi:10.1111/cid.12142 (opens in a new tab) PMID: 24004092 (opens in a new tab).
- Trindade R, Albrektsson T, Tengvall P, Wennerberg A. Foreign Body Reaction to Biomaterials: On Mechanisms for Buildup and Breakdown of Osseointegration. Clin Implant Dent Relat Res. 2016;18(1):192-203. doi:10.1111/cid.12274 (opens in a new tab) PMID: 25257971 (opens in a new tab).
- Hotchkiss KM, Reddy GB, Hyzy SL, Schwartz Z, Boyan BD, Olivares-Navarrete R. Titanium surface characteristics, including topography and wettability, alter macrophage activation. Acta Biomater. 2016;31:425-434. doi:10.1016/j.actbio.2015.12.003 (opens in a new tab) PMID: 26675126 (opens in a new tab).
- International Organization for Standardization. ISO 25178-2: Geometrical product specifications (GPS) - Surface texture: Areal - Part 2: Terms, definitions and surface texture parameters. Geneva: ISO. †
- Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410 (opens in a new tab) PMID: 32663219 (opens in a new tab).
- Reference verification note. 46 of 48 references are PubMed-indexed; their bibliographic records (authors, title, journal, year, volume, pages, DOI, PMID) were retrieved programmatically from the PubMed database on November 17, 2026. † Source not indexed in PubMed (book, standard, guidance or non-indexed journal); bibliographic details are cited from the published record and were not database-verified in this drafting session. Database retrieval confirms that each record exists as cited; it does not replace full-text reading by the responsible authors of every statement attributed to a source.

